Fraud is not a side issue in hospice care; it is now part of the argument over who is protecting patients, taxpayers, and the integrity of Medicare. In testimony before the House Ways and Means Committee on Tuesday, Sheila Clark, president and chief executive officer of the California Hospice and Palliative Care Association, described a system where some providers appear to exist only on paper while patients and public dollars are left exposed.
The central question is no longer whether abuse exists. It is how providers can still operate when, as Clark described, some have no patients, no staff, and even no real office presence. The record presented this week points to a deeper problem: oversight has not kept pace with the growth of the industry, and the result is a fraud environment that is damaging both care and trust.
What does the evidence show about fraud in hospice care?
Verified fact: Clark told lawmakers that fraud in the industry is flourishing in California and said that some hospices operate in name only. She described one office location where “nobody’s there, ” yet mail was stacked up and the provider had still passed a survey. She also questioned how a hospice could be placed in a burrito stand or inside an entire store after licensure, certification, and accreditation processes were supposed to have vetted it.
Her testimony framed fraud as a multi-layered failure, not a single bad actor problem. She said the surge in hospice and home healthcare providers reflects breakdowns across multiple regulatory bodies, weakening patient protections and harming taxpayers. That point matters because the issue is not only false billing; it is the way weak supervision can allow questionable providers to look legitimate long enough to attract Medicare dollars.
Another witness, Dr. Lynn Ianni, a licensed psychotherapist with nearly 40 years of clinical experience, said she was locked out of her Medicare benefits for months after being falsely enrolled in hospice care. She described the experience as terrifying, because she was effectively told she was at the end of her life when she was not. Her account shows how fraud can spill beyond finances and into medical access itself.
Who is affected when fraud reaches Medicare?
The testimony described two kinds of harm: direct damage to patients and broad harm to the public system. One woman told lawmakers about being denied Medicare coverage for a pickleball injury after discovering she had been enrolled in hospice through stolen identity. That example is important because it shows fraud can be used not only to bill for nonexistent patients, but also to block legitimate care from the person whose identity was misused.
Sheila Clark also linked the problem to a larger federal-state oversight dispute. She said California is the clearest current warning sign, but not the only one, and called it a federal Medicare program-integrity problem as well as a state-federal oversight problem. That framing matters because it spreads responsibility beyond one agency or one state office. It suggests that gaps in oversight may be allowing providers to move through the system faster than regulators can check them.
Informed analysis: The most troubling feature of this pattern is how easily a provider can appear legitimate on paper. Dr. Ianni said the hospice that enrolled her showed up on Medicare’s own website, had a National Provider Identifier number, a named chief executive officer, and an address. Yet the address led to what looked like a strip mall and the phone went unanswered. When that kind of disconnect is possible, fraud becomes less about hidden criminality and more about paperwork that is never tested against reality.
What responses are being offered, and what is still missing?
Clark’s response was to push for more scrutiny from both consumers and regulators. She said people should ask their primary care physician a lot of questions when deciding among hospice options. She also said families should ask whether the hospice has a relationship with the patient’s personal physician, what is expected of the family caregiver, and who on the team will be involved in care. Those questions are practical, but they are also a sign that the burden of caution has shifted heavily onto patients.
Sheila Clark’s own association has published guidance for families, whether care will be at a facility or at home, which is where most hospice patients receive services. That guidance signals a system trying to help people navigate risk after the fact, while the underlying oversight question remains unresolved. The hearing also came amid a broader push by the Trump administration to combat healthcare fraud nationwide, including a task force led by Vice President JD Vance that recently suspended 447 hospice providers.
Informed analysis: The political finger-pointing described in the testimony does not answer the practical question of why obvious red flags can survive licensure, certification, accreditation, and survey review. If a provider can exist without staff, without patients, or at an implausible address, then the failure is not just one of enforcement but of basic verification.
For patients and families, the lesson is stark. Fraud is not only an accounting problem. It can decide who gets care, who gets blocked from care, and who is left to untangle the damage. Until regulators can prove that a hospice is real before public money flows to it, California’s warning will remain a test case for the nation.
That is why fraud must be treated as a front-line patient safety issue, not an administrative nuisance. The testimony before Congress makes clear that transparency, tighter verification, and stronger oversight are not optional. They are the minimum needed to prevent the next false hospice from hiding in plain sight under fraud.
